Transcriptional profiling of human herpesvirus type B (HHV-6B) in an adult T cell leukemia cell line as in vitro model for persistent infection

Transcriptional profiling of human herpesvirus type B (HHV-6B) in an adult T cell leukemia cell line as in vitro model for persistent infection
复制标题

DOI:
10.1016/j.bbrc.2005.01.090
复制
发表时间:
2005-04-01
影响因子:
3.1
通讯作者:
Ohyashiki, K
Ohyashiki, K
中科院分区:
生物学4区
文献类型:
--
作者:
Ohyashiki, JH;Takaku, T;Ohyashiki, K

文献摘要

被引文献

相似文献

人类疱疹病毒 6 (HHV-6) 存在于 90% 以上的人体中,已知会导致免疫受损患者(例如移植患者)感染性疾病。为了阐明 HHV-6 基因表达模式在各种类型的 HHV-6B 感染中的可能作用,我们试图确定病毒 DNA 微阵列是否可用于使用包含 97 个已知 HHV-6B 开放阅读框的 HHV-6B DNA 微阵列来详细表征病毒转录。一部分基因在持续性感染中优先表达:U16(IE-B,反式激活蛋白,US22 基因家族),U18(IE-B。HCMV IE 糖蛋白同源物),U20(糖蛋白),U27(DNA 聚合酶持续性反式激活蛋白),U82(gL,gH 辅助蛋白),U83(趋化因子),U85(OX-2 同源性,糖蛋白),U90分别是(IE-A)和U94(反式激活因子)。尽管每个HHV-6B的功能尚不完全清楚,但我们的研究表明,对HHV-6B转录的全面分析不仅有助于阐明病毒的发病机制,而且有助于开发抗病毒药物的新策略。 (C) 2005 Elsevier Inc. 保留所有权利。
Human herpesvirus 6 (HHV-6), which is present in more than 90% of the human, is known to cause infectious diseases in immuno-compromised patients, e.g., transplant patients. To clarify the possible role of the pattern of expression of HHV-6 genes in various types of HHV-6B infection, we sought to determine whether or not viral DNA microarray could be used for detailed characterization of viral transcription using a HHV-6B DNA microarray that contains 97 known open reading frames of HHV-6B. A subset of genes are preferentially expressed in persistent infection: U16 (IE-B, transactivator, US22 gene family), U18 (IE-B. homolog to HCMV IE glycoprotein), U20 (glycoprotein), U27 (DNA polymerase processivity transactivator), U82 (gL, gH accessory protein), U83 (chemokine), U85 (OX-2 homology, glycoprotem), U90 (IE-A), and U94 (transactivator), respectively. Although the function of each HHV-6B is not fully understood, our study suggests that comprehensive analysis of HHV-6B transcription is useful not only to clarify the pathogenesis of the virus but also to develop new strategies for anti-viral drugs. (C) 2005 Elsevier Inc. All rights reserved.